| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |